Since 1923, we have been focused on innovation and leadership in diabetes care. Today we have a broad portfolio of medicines.
Since the launch of our first pen needle in 1985, we have been committed to enhancing injection experience by putting technology in patient hands.
Access information on our products for rare bleeding disorders, growth hormone-related disorders, and women's health.
Find information on our treatment for chronic weight management in adults who are overweight with one weight-related comorbidity or obesity.
The link above used in conjunction with the FDA-approved product labeling may be used to determine U.S. patents associated with the corresponding U.S. marketed product.
Please note, this is not intended to be an exhaustive list of
resources, and Novo Nordisk is not endorsing or recommending any particular
organization listed below.
Measure Height, Measure Health
The MAGIC Foundation
Tel: 1-800-3MAGIC3 (362-4423) magicfoundation.org
Human Growth Foundation
Tel: 1-800-451-6434 E-mail: firstname.lastname@example.org hgfound.org
Tel: 805-499-9973 pituitary.org Regional Support
Groups at: pituitary.org/medical-resources/support-groups/support-groups
Tel: 1-800-365-9944 or 1-832-912-6006 E-mail: email@example.com
Fax: 1-800-594-3862 E-mail: firstname.lastname@example.org www.turnersyndromefoundation.org
E-mail: email@example.com www.teamnoonan.org
Prader-Willi Syndrome Association (USA) National Office
Phone: (800) 926-4797
Foundation for Prader-Willi Research